Stay updated on Zolbetuximab Combo in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab Combo in Gastric Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record now presents details of the Phase 3 zolbetuximab and chemotherapy study for advanced gastric or gastroesophageal junction cancer, including eligibility, treatment arms, outcomes, and study locations. It also provides study documents and individual participant data-sharing information.
    Difference
    100%
    Check dated 2026-11-12T16:00:59.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2, while the study record still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-29T16:18:08.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-22T22:36:31.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 page.
    Difference
    0.2%
    Check dated 2026-10-15T20:54:20.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-08T20:57:58.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating the record is temporarily inaccessible. This prevents viewing of the trial information on the page.
    Difference
    19%
    Check dated 2026-09-24T20:48:50.000Z thumbnail image

Stay in the know with updates to Zolbetuximab Combo in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.